The company had previously halted shipments to certain older patients following the deaths of two teenagers treated with the ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep's return to the U.S. market may have ...

According to multiple reports, a 51-year-old man with limb-girdle muscular dystrophy died from acute liver failure after ...

Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, erasing what had been ...

Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines ...

On a conference call, CEO Doug Ingram said the decision to cut 36% of the company's staff and halt several drug programs was ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

The complaint argues Kennedy’s actions to remove the COVID vaccine from the CDC's immunization schedule for pregnant people ...

One analyst described Cogent’s data as a “home run scenario” for bezuclastinib, which the company is positioning as a ...